Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
Saved in:
| Title: | Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial. |
|---|---|
| Authors: | Balevic SJ; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Benjamin DK Jr; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Powderly WG; Division of Infectious Diseases, Department of Medicine, Washington University in St Louis, St Louis, Missouri., Smith PB; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Gonzalez D; Duke Clinical Research Institute, Durham, North Carolina., McCarthy MW; Department of Medicine, Weill Cornell Medicine, New York, New York., Shaw LK; Duke Clinical Research Institute, Durham, North Carolina., Lindsell CJ; Duke Clinical Research Institute, Durham, North Carolina., Bozzette S; National Center for Advancing Translational Sciences, Bethesda, Maryland., Williams D; Bristol Myers Squibb, Philadelphia, Pennsylvania., Linas BP; Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts., Blamoun J; Department of Critical Care, MyMichigan Health, Midland., Javeri H; Division of Infectious Diseases, Department of Medicine, University of Texas Health Science Center, San Antonio., Hornik CP; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina. |
| Corporate Authors: | ACTIV-1 IM Study Group |
| Source: | JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e247615. Date of Electronic Publication: 2024 Apr 01. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38662372 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Balevic+SJ%22">Balevic SJ</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Benjamin+DK+Jr%22">Benjamin DK Jr</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Powderly+WG%22">Powderly WG</searchLink>; Division of Infectious Diseases, Department of Medicine, Washington University in St Louis, St Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Smith+PB%22">Smith PB</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Gonzalez+D%22">Gonzalez D</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22McCarthy+MW%22">McCarthy MW</searchLink>; Department of Medicine, Weill Cornell Medicine, New York, New York.<br /><searchLink fieldCode="AU" term="%22Shaw+LK%22">Shaw LK</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Lindsell+CJ%22">Lindsell CJ</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Bozzette+S%22">Bozzette S</searchLink>; National Center for Advancing Translational Sciences, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Williams+D%22">Williams D</searchLink>; Bristol Myers Squibb, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Linas+BP%22">Linas BP</searchLink>; Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Blamoun+J%22">Blamoun J</searchLink>; Department of Critical Care, MyMichigan Health, Midland.<br /><searchLink fieldCode="AU" term="%22Javeri+H%22">Javeri H</searchLink>; Division of Infectious Diseases, Department of Medicine, University of Texas Health Science Center, San Antonio.<br /><searchLink fieldCode="AU" term="%22Hornik+CP%22">Hornik CP</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ACTIV-1+IM+Study+Group%22">ACTIV-1 IM Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101729235%22">JAMA network open</searchLink> [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e247615. <i>Date of Electronic Publication: </i>2024 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101729235 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-3805 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225743805%22">25743805 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Netw Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38662372 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamanetworkopen.2024.7615 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e247615 Titles: – TitleFull: Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Balevic SJ – PersonEntity: Name: NameFull: Benjamin DK Jr – PersonEntity: Name: NameFull: Powderly WG – PersonEntity: Name: NameFull: Smith PB – PersonEntity: Name: NameFull: Gonzalez D – PersonEntity: Name: NameFull: McCarthy MW – PersonEntity: Name: NameFull: Shaw LK – PersonEntity: Name: NameFull: Lindsell CJ – PersonEntity: Name: NameFull: Bozzette S – PersonEntity: Name: NameFull: Williams D – PersonEntity: Name: NameFull: Linas BP – PersonEntity: Name: NameFull: Blamoun J – PersonEntity: Name: NameFull: Javeri H – PersonEntity: Name: NameFull: Hornik CP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2574-3805 Numbering: – Type: volume Value: 7 – Type: issue Value: 4 Titles: – TitleFull: JAMA network open Type: main |
| ResultId | 1 |